(Q34631940)

English

Effect of BG-12 on contrast-enhanced lesions in patients with relapsing--remitting multiple sclerosis: subgroup analyses from the phase 2b study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Effect of BG-12 on contrast-enhanced lesions in patients with relapsing--remitting multiple sclerosis: subgroup analyses from the phase 2b study (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

multiple sclerosis

0 references

0 references

relapsing-remitting multiple sclerosis

0 references

1

object named as

Ludwig Kappos

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

2

object named as

Ralf Gold

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

David H. Miller

3

object named as

David H Miller

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

7

object named as

Chris H Polman

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

David G MacManus

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Eva Havrdova

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Volker Limmroth

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Klaus Schmierer

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Tarek A Yousry

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Mefkure Eraksoy

10

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Eva Meluzinova

11

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Michal Dufek

12

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Minhua Yang

13

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Kate Dawson

14

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Gilmore N O'Neill

15

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

30 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

314-321

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458511421054

21 January 2018

Oxidative stress and neurotoxicity

1 reference

https://api.crossref.org/works/10.1177%2F1352458511421054

21 January 2018

Acetylcarnitine induces heme oxygenase in rat astrocytes and protects against oxidative stress: involvement of the transcription factor Nrf2.

1 reference

https://api.crossref.org/works/10.1177%2F1352458511421054

21 January 2018

Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction

1 reference

https://api.crossref.org/works/10.1177%2F1352458511421054

21 January 2018

Increased CD8+ central memory T cells in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458511421054

21 January 2018

Detoxication enzyme inducers modify cytokine production in rat mixed glial cells

1 reference

https://api.crossref.org/works/10.1177%2F1352458511421054

21 January 2018

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

1 reference

https://api.crossref.org/works/10.1177%2F1352458511421054

21 January 2018

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458511421054

21 January 2018

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1177%2F1352458511421054

21 January 2018

Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study

1 reference

https://api.crossref.org/works/10.1177%2F1352458511421054

21 January 2018

A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458511421054

21 January 2018

Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process

1 reference

https://api.crossref.org/works/10.1177%2F1352458511421054

21 January 2018

Mitochondrial Protein Nitration Primes Neurodegeneration in Experimental Autoimmune Encephalomyelitis

1 reference

https://api.crossref.org/works/10.1177%2F1352458511421054

21 January 2018

Identifiers

10.1177/1352458511421054

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34631940&oldid=1772736077"